Doctors Note Logo

Published on: 10/1/2026

Why some people avoid Tdap in pregnancy, and what is actually advised

Some pregnant people delay or decline the Tdap vaccine because of worries about fetal safety, confusion over timing, fear of side effects like soreness or low-grade fever, or mixed messages from family and social media, yet decades of monitoring show no increased risk of birth defects, miscarriage, or preterm birth. What is actually advised is a single Tdap dose during every pregnancy, ideally between 27 and 36 weeks, so protective antibodies cross the placenta and shield the newborn from whooping cough in the first vulnerable months before their own shots begin. There are several important factors to consider, including prior vaccination history, specific allergy concerns, and what to do if the window is missed, so see below for the complete details.

If you are pregnant and experiencing a lingering cough, fever, or other symptoms that make you hesitant about vaccination timing, getting clarity quickly matters for both you and your baby. Take a free, instant, online symptom check to better understand what may be going on and to see sensible next steps before your next prenatal visit.

Last reviewed for medical accuracy: 10/01/2025

answer background

Explanation

Why Some People Avoid Tdap During Pregnancy

Tdap (tetanus-diphtheria-acellular pertussis) vaccination during pregnancy is recommended by leading medical organizations, yet some expectant parents hesitate. Common reasons include:

  • Concerns about vaccine safety in pregnancy
  • Fear of side effects for mother or baby
  • Worries about vaccine ingredients (e.g., thimerosal or aluminum)
  • Belief that natural immunity or delaying the vaccine is better
  • Influence of misinformation or anti-vaccine messaging

Understanding these concerns and reviewing the evidence can help you make an informed choice.


What Credible Resources Advise

Major public health bodies and professional societies, including the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG), agree:

  1. Tdap Is Safe in Pregnancy

    • Numerous large-scale studies show no increase in serious adverse events for mother or baby.
    • No link to miscarriage, birth defects or preterm birth.
  2. Timing Is Key

    • Optimal window: 27–36 weeks’ gestation.
    • Vaccinating in this period maximizes transfer of protective antibodies to your newborn.
  3. Protection for Your Newborn

    • Babies don’t start their own pertussis vaccines until 2 months of age.
    • Maternal antibodies passed through the placenta help shield them during that vulnerable gap.
  4. Repeat Each Pregnancy

    • Even if you received Tdap before, you need another dose with each pregnancy to boost antibody levels.

Evidence Summary

  • A 2020 systematic review of over 50,000 pregnant women found no increased risk of:
    • Preterm birth
    • Low birth weight
    • Hypertensive disorders of pregnancy
  • Multiple surveillance systems track vaccine safety in pregnant people. Findings consistently support a favorable safety profile.
  • Pertussis (“whooping cough”) infections in newborns can be severe, sometimes leading to hospitalization or life-threatening complications. Maternal vaccination reduces that risk by up to 90%.

Common Side Effects

Like all vaccines, Tdap can cause mild, temporary reactions. These are normal signs your immune system is responding:

  • Soreness, redness or swelling at the injection site (up to 3 days)
  • Low-grade fever or headache
  • Mild fatigue or muscle aches
  • Rarely, an allergic reaction (seek immediate care if you develop hives, swelling of the face/lips or difficulty breathing)

These side effects are usually much milder than the potential severity of pertussis infection in a newborn.


Addressing Ingredient Concerns

  • Thimerosal: Most Tdap formulations for pregnant people are thimerosal-free.
  • Aluminum salts: Used in very small amounts as adjuvants to boost immunity; levels are lower than what we’re routinely exposed to in food and water.

All ingredients meet strict safety standards and have a long history of use in vaccines.


Why Timing Matters

  • Giving Tdap before 27 weeks may not produce enough antibodies in time for transfer to the fetus.
  • After 36 weeks, there’s less time for antibody development and transfer before birth.
  • If you deliver early and didn’t get Tdap, providers may offer it immediately postpartum to protect future pregnancies.

Talking It Through with Your Healthcare Provider

Your obstetrician, midwife or primary care doctor can answer questions about:

  • Your personal health history and any allergy concerns
  • Local pertussis activity or outbreaks in your community
  • How Tdap fits into your overall prenatal care plan

If you’re experiencing any symptoms or just want to check on general health issues during pregnancy, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.


Key Takeaways

  • Major health authorities recommend Tdap between 27 and 36 weeks of every pregnancy.
  • Vaccination is safe, with only mild side effects in most people.
  • Maternal antibodies protect newborns against whooping cough until they can start their own immunizations.
  • Concerns about ingredients or safety are understandable but not supported by high-quality evidence.
  • Always discuss any vaccine questions or health worries with your care provider.

Disclaimer: This information is intended for educational purposes and should not replace professional medical advice. If you have life-threatening symptoms or serious health concerns, please speak to a doctor immediately.

(References)

  • * Share with women. Preventing pertussis (whooping cough). J Midwifery Womens Health. 2013 May-Jun;58(3):357-8. doi: 10.1111/jmwh.12067. Epub 2013 Apr 29. PMID: 23627970.

  • * Gilley M, Goldman RD. Response. Can Fam Physician. 2014 Jun;60(6):521-2. PMID: 24925938; PMCID: PMC4055314.

  • * Leuridan E. Pertussis vaccination in pregnancy: State of the art. Vaccine. 2017 Aug 16;35(35 Pt A):4453-4456. doi: 10.1016/j.vaccine.2017.03.061. Epub 2017 Mar 27. PMID: 28359620.

  • * Cabrera-Maqueda JM, Hernández-Clares R, Baidez-Guerrero AE, Pío-Rendón JIB, Fernández JJM. Optic neuritis in pregnancy after Tdap vaccination: Report of two cases. Clin Neurol Neurosurg. 2017 Sep;160:116-118. doi: 10.1016/j.clineuro.2017.07.002. Epub 2017 Jul 11. PMID: 28719871.

  • * Munoz FM, Jamieson DJ. Maternal Immunization. Obstet Gynecol. 2019 Apr;133(4):739-753. doi: 10.1097/AOG.0000000000003161. PMID: 30913173.

  • * Jina A, Wang TL, Seyferth ER, Cohen A, Bernstein HH. Increasing antepartum Tdap vaccine administration: A quality improvement initiative. Vaccine. 2019 Jun 19;37(28):3654-3659. doi: 10.1016/j.vaccine.2019.05.045. Epub 2019 May 20. PMID: 31122862.

  • * Broderick D. The Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration. Ir Med J. 2019 Sep 12;112(8):982. Epub 2019 Sep 12. PMID: 31647210.

  • * Heavey E. Guiding patients to appropriate vaccination during pregnancy. Nurse Pract. 2020 Jun;45(6):19-24. doi: 10.1097/01.NPR.0000666180.07149.f6. PMID: 32345831.

  • * Bernstein HH, Tong-Miller S, Cleary SS, Sherin M, Spino C. Factors Influencing Maternal Antepartum Tdap Vaccination. Matern Child Health J. 2022 Dec;26(12):2385-2395. doi: 10.1007/s10995-022-03557-5. Epub 2022 Sep 29. PMID: 36173502; PMCID: PMC9519405.

  • * Harvey A, Tabatabai M, Wilus D, Thomas S, Hildreth JEK, Alcendor DJ. Vaccinations for Expecting Mothers to Improve Pregnancy Care in Middle Tennessee. Pathogens. 2025 Dec 8;14(12). doi: 10.3390/pathogens14121255. Epub 2025 Dec 8. PMID: 41471210; PMCID: PMC12735586.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.